Virtual Medicinal Product (VMP) - Levocabastine 0.05% nasal spray
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Levocabastine 0.05% nasal spray | Start Date 12-02-2003 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Nasal
- Form
- Spray
- Ontology Form/Route
- suspensionspray.nasal
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- R01AC02
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 12020100 | Start Date 04-04-2022 | End Date |
| Previous BNF 12020100 | Start Date 17-02-2005 | End Date 26-04-2006 |
| Code | Start Date | End Date |
|---|---|---|
| 3875811000001101 | 12-02-2003 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Levocabastine hydrochloride | Based on Base Substance | Levocabastine | 500 microgram | 1 ml |
Name
Levocabastine hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Levocabastine
Strength and UOM (Nmr)
500.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMLevocabastine
-
VMP(Current) Levocabastine 0.05% nasal spray
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 5 ml | ||
| 10 ml |